Clinical Trials Sponsored by Jennerex Biotherapeutics
Total 359 results
-
Jennerex BiotherapeuticsTerminated
-
Jennerex BiotherapeuticsCompletedHCC | Hepatocellular Carcinoma | Liver CancerKorea, Republic of, United States, Hong Kong, Canada, Germany, France, Taiwan
-
Jennerex BiotherapeuticsCompleted
-
Jennerex BiotherapeuticsCompletedCarcinoma, HepatocellularKorea, Republic of
-
Jennerex BiotherapeuticsCompletedHepatocellular CarinomaUnited States, Korea, Republic of, Spain
-
Jennerex BiotherapeuticsCompletedMelanoma | Renal Cell Carcinoma | Lung Cancer | Squamous Cell Carcinoma of the Head and NeckUnited States, Canada
-
Jennerex BiotherapeuticsCompletedCarcinoma, HepatocellularUnited States, Korea, Republic of, Canada
-
Jennerex BiotherapeuticsGreen Cross CorporationCompleted
-
Jennerex BiotherapeuticsTransgeneCompletedColorectal Carcinoma | CRCCanada, United States, France
-
Jennerex BiotherapeuticsSolving Kids' CancerCompletedLymphoma | Neuroblastoma | Rhabdomyosarcoma | Wilm's Tumor | Ewing's SarcomaUnited States
-
Jennerex BiotherapeuticsSamsung Medical CenterCompletedCarcinoma, ColorectalKorea, Republic of
-
Fore BiotherapeuticsRecruitingCancer Harboring BRAF AlterationsUnited States, Germany, Spain, United Kingdom, France, Korea, Republic of, Italy, Sweden, Canada
-
Sonnet BioTherapeuticsRecruitingAdvanced Solid TumorUnited States
-
Atara BiotherapeuticsRecruitingLymphoproliferative Disorders | Leiomyosarcoma | Stem Cell Transplant Complications | Solid Organ Transplant Complications | Epstein-Barr Virus (EBV)-Associated Diseases | EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD) | Allogeneic Hematopoietic Cell Transplant | EBV+ Sarcomas | EBV+ Lymphoproliferative... and other conditionsUnited States, Austria, Belgium, France, Italy, Spain, United Kingdom
-
Atara BiotherapeuticsRecruitingLymphoproliferative Disorders | Stem Cell Transplant Complications | Solid Organ Transplant Complications | Allogeneic Hematopoietic Cell Transplant | Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)United States, Austria, Australia, Belgium, Canada, France, Italy, Spain, United Kingdom
-
Tavotek BiotherapeuticsActive, not recruiting
-
Tavotek BiotherapeuticsCompleted
-
Revolo BiotherapeuticsCompletedEosinophilic EsophagitisUnited States
-
Revolo BiotherapeuticsCompletedHealthy VolunteerUnited States
-
Sonnet BioTherapeuticsCompleted
-
Aeglea BiotherapeuticsTerminatedHomocystinuria Due to Cystathionine Beta-Synthase DeficiencyUnited States, United Kingdom, Australia
-
Atara BiotherapeuticsNo longer availableLymphoproliferative Disorders | Stem Cell Transplant Complications | Epstein-Barr Virus (EBV) Infections | EBV+ Associated Lymphoma | EBV+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD) | Epstein-Barr Viremia | Lymphoma, AIDS-related | Epstein-Barr Virus-associated Lymphoproliferative... and other conditions
-
Fore BiotherapeuticsCompletedPatients That Have Been Diagnosed With Colorectal Cancer | Patients Eligible for Tumor BiopsyIsrael
-
Eleven BiotherapeuticsWithdrawn
-
Eleven BiotherapeuticsUnknown
-
Atara BiotherapeuticsNot yet recruitingSystemic Lupus Erythematosus | Lupus Nephritis
-
Fore BiotherapeuticsRecruitingHealthy VolunteerUnited States
-
Atara BiotherapeuticsRecruitingHigh-grade B-cell Lymphoma | MCL | Diffuse Large B-cell Lymphoma (DLBCL) | Relapsed/Refractory B-cell Non-Hodgkin Lymphoma | DLBCL/High-grade B-cell Lymphoma With MYC and BCL2 Rearrangements | Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma | LBCL With IRF4 Rearrangement | High-grade B-cell... and other conditionsUnited States
-
Alethia BiotherapeuticsRecruitingMetastatic Colorectal CancerCanada
-
Tavotek BiotherapeuticsRecruiting
-
Aro BiotherapeuticsRecruiting
-
Latigo BiotherapeuticsRecruiting
-
Barinthus BiotherapeuticsCompletedHPV Infection | CIN1Belgium, United Kingdom, Estonia
-
BrightPath BiotherapeuticsTerminated
-
Northwest BiotherapeuticsActive, not recruitingGlioma | Glioblastoma | Brain Cancer | Brain Tumor | Glioblastoma Multiforme | GBM | Grade IV AstrocytomaUnited States, Germany, Canada, United Kingdom
-
Aeglea BiotherapeuticsCompletedAdvanced CancersUnited States
-
Alethia BiotherapeuticsCompletedSolid Tumor | Metastatic CancerCanada
-
Eleven BiotherapeuticsCompleted
-
Eleven BiotherapeuticsCompletedA Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1)Allergic ConjunctivitisCanada
-
Eleven BiotherapeuticsCompleted
-
Eleven BiotherapeuticsCompleted
-
Northwest BiotherapeuticsWithdrawnProstate CancerUnited States
-
Tavotek BiotherapeuticsRecruiting
-
Excision BioTherapeuticsActive, not recruiting
-
Excision BioTherapeuticsEnrolling by invitationHIV-1-infectionUnited States
-
Sonnet BioTherapeuticsTerminatedChemotherapy-induced Peripheral Neuropathy (CIPN)Australia
-
Fore BiotherapeuticsActive, not recruitingAdvanced Unresectable Solid Tumors | BRAF-mutated TumorsUnited States
-
Alethia BiotherapeuticsCompletedNSCLC Stage IVUnited States, Canada
-
Atara BiotherapeuticsTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States, Australia, Canada